Georgia 2023-2024 Regular Session

Georgia House Bill HB440

Introduced
2/15/23  
Report Pass
2/22/23  
Introduced
2/15/23  
Engrossed
2/27/23  
Report Pass
2/22/23  
Refer
2/28/23  
Engrossed
2/27/23  
Report Pass
3/8/23  
Refer
2/28/23  
Enrolled
3/30/23  
Report Pass
3/8/23  
Chaptered
4/13/23  
Enrolled
3/30/23  
Chaptered
4/13/23  

Caption

Education; authorize public and private schools to stock a supply of undesignated ready-to-use glucagon

Impact

The bill will amend existing laws related to student health and the roles of pharmacists in Georgia. By allowing schools to stock glucagon, it introduces a standardized procedure for emergency situations involving severe hypoglycemia. This change aims to enhance the safety of students with diabetes, providing educational institutions with the tools they need to respond effectively to such emergencies. It is also anticipated to encourage collaboration between schools and healthcare professionals, fostering a supportive environment for student health management.

Summary

House Bill 440 aims to enhance student health in Georgia by authorizing public and private schools to stock a supply of undesignated ready-to-use glucagon. This medication is crucial for treating severe hypoglycemia, particularly for students with diabetes. The bill includes definitions regarding glucagon, mandates training for school staff, and outlines regulations for the storage, maintenance, and distribution of the medication. The intended outcome is to ensure that schools are prepared to provide immediate care in emergencies related to hypoglycemia among students.

Sentiment

The sentiment surrounding HB 440 is largely positive, with support from legislators and advocacy groups emphasizing the importance of preparedness in schools for health emergencies. By equipping schools with the ability to administer glucagon, proponents argue that the bill will save lives and offer peace of mind to parents of diabetic children. However, discussions may arise regarding the responsibilities placed on school staff and the necessity of ensuring comprehensive training before implementation.

Contention

While the bill is generally well-received, potential points of contention include the logistical aspects of staff training and the financial implications for schools in obtaining the glucagon. Critics may raise concerns about the feasibility of ensuring that all schools can comply with the new requirements, particularly in lower-funded districts. Moreover, the adequacy of training provided to non-medical staff in school settings could be scrutinized to ensure that students are genuinely safe in emergency situations.

Companion Bills

No companion bills found.

Previously Filed As

GA A4548

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

GA H671

Relative to undesignated glucagon rescue therapies in schools

GA SB3051

SCH CD-UNDESIGNATED GLUCAGON

GA HB75

AN ACT relating to undesignated glucagon.

GA HB174

AN ACT relating to undesignated glucagon.

GA HB263

AN ACT relating to undesignated glucagon.

GA HB350

Relating to the use of glucagon medication on certain public and private school campuses.

GA SB92

Glucagon for Schools Act

GA SB0146

Glucagon Amendments

GA HB1363

Education; authorize public schools and postsecondary educational institutions to consider antisemitism in the same manner as discrimination based on religion

Similar Bills

FL H0597

Diabetes Management in Schools

NJ A4548

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

WV SB92

Glucagon for Schools Act

FL S0772

Diabetes Management in Schools

KY HB75

AN ACT relating to undesignated glucagon.

KY HB174

AN ACT relating to undesignated glucagon.

FL HB597

Diabetes Management in Schools:

KY HB263

AN ACT relating to undesignated glucagon.